Plain-English translation of NCT05939401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Anal Cancer research guide →This research study is collecting small tissue samples (biopsies) and blood samples from people with anal cancer to better understand how their tumors respond to treatment. Researchers want to learn whether looking at the tissue under a microscope can predict which patients will do well with standard cancer treatments and which may need different approaches. By studying these samples, doctors hope to personalize care for future patients.
Right now, doctors treat all anal cancer patients with similar approaches, but some respond much better than others. This study exists to find out whether examining tumor tissue early on can predict who will benefit most from standard treatment, helping doctors make better treatment decisions sooner.
You likely qualify if…
You likely don't qualify if…
If you join this study, tissue samples and blood will be collected as part of your regular cancer care — during your diagnostic examination, during follow-up visits, or during any surgery you may need. These samples are taken at the same time as your standard medical procedures, so you won't need extra visits. Researchers will then study these samples in the lab to understand how your tumor responds to treatment.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Sweden
Sahlgrenska University Hospital
Collaborators
Göteborg University
Enrollment target
~400 participants
Started
December 2023
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eva Angenete PI, Professor
Sahlgrenska University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.